Three things to know:
1. The mild procedure is an outpatient LSS treatment. It is designed to restore space in the spinal canal using specialized mild devices to remove hypertrophic ligamentum flavum through a 5.1-mm treatment portal.
2. The mild device kit and procedure can now be marketed and sold in 32 European countries.
“Receiving the CE mark is an important step for the company to be able to offer the mild procedure outside of the United States,” said Eric Wichems, President and CEO of Vertos Medical.
3. The procedure, which received broad CMS coverage in 2016, has been performed on more than 20,000 patients.
More articles on devices:
RTI Surgical reports $71.2M in Q4 revenue & more: 10 device company notes
Mighty Oak Medical named solution provider of the year: 3 things to know
OrthoGrid Systems receives FDA clearance for new orthopedic distortion adaptation technology
